Carlo A. Waldemar M.D. is Director at MEDNAX, INC. (MD). They have made 7 open-market trades across 1 company since 2011, most recently 2021-05-12.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MD | 36,687 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2021-05-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MD | SELL | 2017-02-09 | 2017-02-10 | $67.90 | $724K | +1.9% | +3.0% | -19.0% |
| MD | SELL | 2016-06-08 | 2016-06-10 | $70.50 | $376K | +4.7% | +10.7% | -2.1% |
| MD | SELL | 2015-02-20 | 2015-02-23 | $71.50 | $763K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2014-02-10 | 2014-02-10 | $55.40 | $591K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2013-02-01 | 2013-02-04 | $85.66 | $685K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2012-02-03 | 2012-02-03 | $71.70 | $574K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2011-03-10 | 2011-03-11 | $67.02 | $536K | -6.0% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.